Personal Site of GEECS
The Global Economics and Evaluation of Clinical Genomics Sequencing Working Group (GEECS), founded in 2017, aims to improve the methods used for assessing the value and implementation of new genomic technologies – specifically, clinical genomics testing using next-generation sequencing (NGS).
To facilitate effective, efficient, and equitable use of clinical genomic sequencing (CGS) on a global scale
To conduct evidence-based research and share information to advance value and implementation of CGS
Visibility/Dissemination: Continue to be widely known as the experts on applying economic and similar methods to CGS.
Impact/Influence: Impact how evaluations of CGS are conducted and used. Ensure more evidence on CGS is generated, evaluations are of high quality, and evidence is appropriately used in decision-making.
Leverage: Leverage the expertise of our community of experts and share information such that the sum is greater than the parts